What is Naturewise Biotech & Medicals Price-to-Operating-Cash-Flow?
As of today (2024-06-06), Naturewise Biotech & Medicals's share price is NT$26.90.
Naturewise Biotech & Medicals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1.25. Hence, Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow Ratio for today is 21.59.
The historical rank and industry rank for Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow or its related term are showing as below:
ROCO:4732'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 18.18 Med: 56.68 Max: 139.29
Current: 21.59
During the past 13 years, Naturewise Biotech & Medicals's highest Price-to-Operating-Cash-Flow Ratio was 139.29. The lowest was 18.18. And the median was 56.68.
Naturewise Biotech & Medicals's Cash Flow from Operations per share for the
six
months ended in Dec. 2023 was NT$0.72.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1.25.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Naturewise Biotech & Medicals was 345.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 3.40% per year.
During the past 13 years, Naturewise Biotech & Medicals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 26.50% per year. The lowest was -66.20% per year. And the median was -19.20% per year.
Naturewise Biotech & Medicals Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturewise Biotech & Medicals Price-to-Operating-Cash-Flow Chart
|
Naturewise Biotech & Medicals Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
65.27 |
22.62 |
72.91 |
125.36 |
22.11 |
|
Naturewise Biotech & Medicals Semi-Annual Data
|
|
Jun14 |
Dec14 |
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
72.91 |
- |
125.36 |
- |
22.11 |
Competitive Comparison of Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow falls into.
Naturewise Biotech & Medicals Price-to-Operating-Cash-Flow Calculation
Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 26.90 | / | 1.246 |
| = | 21.59 |
Naturewise Biotech & Medicals's Share Price of today is NT$26.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Naturewise Biotech & Medicals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Naturewise Biotech & Medicals (ROCO:4732) Business Description
Traded in Other Exchanges
N/A
Address
No. 36, Bade Road, 6th Floor, Section 3, Taipei, TWN, 105
Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.
Naturewise Biotech & Medicals (ROCO:4732) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:4732 has been successfully added to your